- Oops!Something went wrong.Please try again later.
The construction company plans to raise some cash, but investors appear a little worried about the way it's doing it.
Shares of Curevac NV plunged more than 50% in the extended session Wednesday after the pharma company said its trial COVID-19 vaccine showed an efficacy of 47% against the illness.
His administration is giving relief to borrowers who brought claims against their school.
FA CENTER Lumber prices have experienced one of their biggest and quickest plunges in history— with the spot futures contract dropping more than $670, or 40%, in just 25 trading sessions. It’s human nature to try to find meaning in this, since the alternative is to accept that price changes this momentous are nothing more than merely random fluctuations.
Shares of The Trade Desk (NASDAQ: TTD) are about to get a whole heck of a lot cheaper, but it isn't because the company is in any sort of trouble. In a press release announcing the move, management said that the "goal of the split is to make The Trade Desk stock more accessible to our employees and a broader base of investors." Since The Trade Desk debuted on Sept. 21, 2016, at $28.75 a share, the stock has been on fire, climbing to roughly $592 as of this writing, gaining a massive 1,959%.
Prices have dropped from record highs spurred by the economic reopening, potentially pointing to an eventual return to normalcy.
(Bloomberg) -- Japanese authorities may issue vaccine passports for residents as soon as mid-July, according to broadcaster NHK. The host nation of the Olympics plans to allow spectators to attend the games, while the state of emergency for Tokyo is set to expire on Sunday.German firm CureVac NV’s Covid-19 vaccine was only 47% effective, falling well short of the high bar set by other messenger RNA shots. Moderna Inc. said the U.S. government exercised the option to buy 200 million more doses of
Portugal captain held up bottle of water and shouted in Portuguese: ‘Agua!’
Nvidia (NVDA) will likely not be able to meet its March 2022 deadline to complete its $40 billion acquisition of Arm Ltd., according to Reuters. Shares of the multinational technology company designing graphics processing units for the gaming, mobile computing, and automotive markets were down 1.3% to close at $711.54 on June 15. The delay is due to European regulators’ unwillingness to look into the deal before the end of the summer holidays. The deal was first announced last year and led to an
The S&P 500 is chugging along nicely with a 14% gain year to date, but stocks like Apple (NASDAQ: AAPL) and Amazon (NASDAQ: AMZN) -- both of which came out with mind-blowing revenue and earnings numbers earlier in the year -- have somehow failed to climb. Clovis Oncology (NASDAQ: CLVS) may fit that bill. As a biotech aimed at improving and saving lives, Clovis is focused on advancing the fight against cancer with treatments for patients across the U.S., Europe, and internationally.
Miller/Howard Investments, an investment management firm, published its first quarter 2021 investor letter – a copy of which can be downloaded here. Miller/Howard’s Infrastructure Strategy remains well-positioned to capitalize on momentum toward value and income stocks. The strategy has a yield over twice that of the S&P 500 and is trading well-below the broader market’s […]
Soccer great Cristiano Ronaldo sends a jolt to Coke's investors.
Shares of vaccine start-up (CVAC) lost half their value in Wednesday’s after-hours trading following the German company’s announcement that the preliminary data from its Covid-19 study are disappointing. In a pivotal trial among 40,000 volunteers, the shots were 47% effective at preventing Covid symptoms. “While we were hoping for a stronger interim outcome, we recognize that demonstrating high efficacy in this unprecedented broad diversity of variants is challenging,” said CureVac chief executive Dr. Franz-Werner Haas.
Dogecoin has seen its value increase exponentially over the past year, but is it an asset worthy of serious consideration or a speculative bubble waiting to burst? One analyst thinks the latter.
A California judge on Tuesday dismissed a lawsuit brought by rapper Ice Cube against trading platform Robinhood claiming the trading platform used his image to promote its products, without his consent. The rapper sued Robinhood in March, alleging that it was damaging his reputation and violating trademark law by using his image and a take on his musical lyrics, and making it appear as if he endorsed the company, without his consent, in its "Robinhood Snacks" newsletter.
In this article, we discuss the top Chinese companies on NASDAQ. If you want to skip our detailed analysis of these companies, go directly to the Top 5 Chinese Companies on NASDAQ. Chinese companies have taken the American stock market by storm in recent years as Beijing gradually opens up to investments from the outside […]
(Bloomberg) -- Peter and Lynette Griffith had two-thirds of their retirement savings in shares during the 2008 financial crisis. By the time they stopped contributing to their pension fund last year, it was 100%.“There’s the 60/40 split, or for us personally, we used to have a 70/30 rule -- 70% shares, 30% fixed-income -- for a decent return,” said Peter, a retired banker in Brisbane. “Those days are long gone. You just can’t live on the income anymore from term deposits or bonds.”The Griffiths
The saga of Theranos, a unicorn biotech startup, and its enigmatic CEO, Elizabeth Holmes, from the rise to the fall and its aftermath.
Rolls-Royce Holdings plc ( LON:RR. ) is possibly approaching a major achievement in its business, so we would like to...
Dynavax Technologies (NASDAQ: DVAX) stock was down 6.3% as of 11:26 a.m. EDT, while shares of Novavax (NASDAQ: NVAX) and Vaxart (NASDAQ: VXRT) were falling 7.8% and 10.6%, respectively. The declines for the biotech stocks appear to merely be run-of-the-mill volatility on a day when the overall stock market was down. Sales of its Heplisav-B hepatitis B vaccine were negatively impacted by the COVID-19 pandemic.
Who is buying stocks and cryptos from me when I’ve trimmed and sold for the past month or so? Sure, there are banks and institutions and hedge funds and family offices investing and trading, just as always.